Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


2 Am J Hematol
1 Biochem Biophys Res Commun
1 Blood
1 BMC Cancer
2 Eur J Haematol
1 Exp Hematol
1 Genes Chromosomes Cancer
7 Leuk Lymphoma
6 Leukemia
1 N Engl J Med
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Hematol

  1. FANG H, Reichard KK, Rabe KG, Hanson CA, et al
    IGH translocations in chronic lymphocytic leukemia (CLL): clinicopathologic features and clinical outcomes.
    Am J Hematol. 2018 Dec 21. doi: 10.1002/ajh.25385.
    PubMed     Text format     Abstract available

  2. ANAND K, Kumar P, Pingali SR, Pati D, et al
    Acute Myeloid Leukemia with Eosinophilia (AML-M4Eo) after Cyclin Dependent Kinases 4/6 Inhibitor Treatment Due to Underlying Clonal Hematopoiesis of Indeterminate Potential (CHIP).
    Am J Hematol. 2018 Dec 21. doi: 10.1002/ajh.25380.
    PubMed     Text format    

    Biochem Biophys Res Commun

  3. ZHANG Y, Huang Z, Sheng F, Yin Z, et al
    MYC upregulated LINC00319 promotes human acute myeloid leukemia (AML) cells growth through stabilizing SIRT6.
    Biochem Biophys Res Commun. 2018 Dec 23. pii: S0006-291X(18)32798.
    PubMed     Text format     Abstract available


  4. BEAUCHAMP EM, Abedin SM, Radecki SG, Fischietti M, et al
    Identification and targeting of novel CDK9 complexes in acute myeloid leukemia.
    Blood. 2018 Dec 26. pii: blood-2018-08-870089. doi: 10.1182/blood-2018-08-870089
    PubMed     Text format     Abstract available

    BMC Cancer

  5. TAROKHIAN H, Rahimi H, Mosavat A, Shirdel A, et al
    HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
    BMC Cancer. 2018;18:1287.
    PubMed     Text format     Abstract available

    Eur J Haematol

  6. ZAWITKOWSKA J, Lejman M, Zaucha-Prazmo A, Drabko K, et al
    Clinical characteristics and analysis of treatment result in children with Ph-positive acute lymphoblastic leukaemia in Poland between 2005 and 2017.
    Eur J Haematol. 2018;101:542-548.
    PubMed     Text format     Abstract available

  7. GRIFFIN JD, Yang H, Song Y, Kinrich D, et al
    Treatment Patterns and Healthcare Resource Utilization in Patients with FLT3-Mutated and Wild Type Acute Myeloid Leukemia: A Medical Chart Study.
    Eur J Haematol. 2018 Dec 22. doi: 10.1111/ejh.13205.
    PubMed     Text format     Abstract available

    Exp Hematol

  8. NARAYAN N, Bracken CP, Ekert PG
    MicroRNA-155 expression and function in AML: An evolving paradigm.
    Exp Hematol. 2018;62:1-6.
    PubMed     Text format     Abstract available

    Genes Chromosomes Cancer

  9. MARTIN-GUERRERO I, Salaverria I, Burkhardt B, Chassagne-Clement C, et al
    Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Genes Chromosomes Cancer. 2018 Dec 22. doi: 10.1002/gcc.22726.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  10. BODDU P, Oviedo SP, Rausch CR, Yam C, et al
    PET-CT in AML-related hemophagocytic lymphohistiocytosis.
    Leuk Lymphoma. 2018;59:1486-1489.
    PubMed     Text format    

  11. BODDU P, Shah AR, Borthakur G, Verstovsek S, et al
    Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting.
    Leuk Lymphoma. 2018;59:1312-1322.
    PubMed     Text format     Abstract available

  12. VAKHARIA P, Nardone B, Budris W, Hoshizaki K, et al
    Blinatumomab and pancreatitis: an analysis of FAERS, EudraVigilance, and a large urban U.S. patient population data.
    Leuk Lymphoma. 2018;59:1759-1761.
    PubMed     Text format    

  13. BURKE MJ, Devidas M, Maloney K, Angiolillo A, et al
    Severe pegaspargase hypersensitivity reaction rates (grade >/=3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials.
    Leuk Lymphoma. 2018;59:1624-1633.
    PubMed     Text format     Abstract available

  14. DASGUPTA Y, Golovine K, Nieborowska-Skorska M, Luo L, et al
    Drugging DNA repair to target T-ALL cells.
    Leuk Lymphoma. 2018;59:1746-1749.
    PubMed     Text format    

  15. STRATI P, Tang G, Duose DY, Mallampati S, et al
    Myeloid/lymphoid neoplasms with FGFR1 rearrangement.
    Leuk Lymphoma. 2018;59:1672-1676.
    PubMed     Text format     Abstract available

  16. HIWASE D, Ross D
    Success is built on failures: tackling the challenge of ponatinib failure.
    Leuk Lymphoma. 2018;59:1279-1281.
    PubMed     Text format    


  17. HANNA BS, Roessner PM, Scheffold A, Jebaraj BMC, et al
    PI3Kdelta inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.
    Leukemia. 2018 Dec 20. pii: 10.1038/s41375-018-0318.
    PubMed     Text format     Abstract available

  18. BORGA C, Foster CA, Iyer S, Garcia SP, et al
    Molecularly distinct models of zebrafish Myc-induced B cell leukemia.
    Leukemia. 2018 Dec 20. pii: 10.1038/s41375-018-0328.
    PubMed     Text format    

  19. EFFICACE F, Breccia M, Avvisati G, Cottone F, et al
    Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia.
    Leukemia. 2018 Dec 20. pii: 10.1038/s41375-018-0325.
    PubMed     Text format     Abstract available

  20. SCHETELIG J, de Wreede LC, van Gelder M, Koster L, et al
    Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia.
    Leukemia. 2018 Dec 20. pii: 10.1038/s41375-018-0302.
    PubMed     Text format     Abstract available

  21. VELAZQUEZ-AVILA M, Balandran JC, Ramirez-Ramirez D, Velazquez-Avila M, et al
    High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse.
    Leukemia. 2018 Dec 20. pii: 10.1038/s41375-018-0333.
    PubMed     Text format     Abstract available

  22. ZHAO J, Liang JW, Xue HL, Shen SH, et al
    The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
    Leukemia. 2018 Dec 21. pii: 10.1038/s41375-018-0338.
    PubMed     Text format     Abstract available

    N Engl J Med

  23. LOREN AW
    Harder to Treat Than Leukemia - Opioid Use Disorder in Survivors of Cancer.
    N Engl J Med. 2018;379:2485-2487.
    PubMed     Text format    

    PLoS One

  24. NORGAARD CH, Sogaard NB, Biccler JL, Pilgaard L, et al
    Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study.
    PLoS One. 2018;13:e0208180.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.